Russell Investments Group
AXSM icon

Russell Investments Group’s Axsome Therapeutics AXSM Stock Holding History

Russell Investments Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8M Buy
60,592
+24,874
+70% +$5.39M 0.01% 864
2026
Q1 		$6.04M Buy
35,718
+143
+0.4% +$24.7K 0.01% 1245
2025
Q4 		$6.5M Buy
35,575
+9,973
+39% +$1.39M 0.01% 1156
2025
Q3 		$3.11M Buy
25,602
+7,798
+44% +$878K ﹤0.01% 1611
2025
Q2 		$1.86M Buy
17,804
+15,166
+575% +$1.61M ﹤0.01% 1755
2025
Q1 		$308K Sell
2,638
-16,799
-86% -$1.91M ﹤0.01% 2470
2024
Q4 		$1.64M Buy
19,437
+18,422
+1,815% +$1.69M ﹤0.01% 1765
2024
Q3 		$91.2K Sell
1,015
-819
-45% -$71.5K ﹤0.01% 2676
2024
Q2 		$148K Buy
1,834
+1,043
+132% +$77.2K ﹤0.01% 2546
2024
Q1 		$63.1K Buy
791
+777
+5,550% +$65.2K ﹤0.01% 2635
2023
Q4 		$1.11K Sell
14
-8,950
-100% -$598K ﹤0.01% 3053
2023
Q3 		$626K Sell
8,964
-15,635
-64% -$1.17M ﹤0.01% 2147
2023
Q2 		$1.77M Buy
24,599
+24,578
+117,038% +$1.81M ﹤0.01% 1633
2023
Q1 		$1.29K Buy
+21
New +$1.38K ﹤0.01% 3038
2021
Q4 		– Sell
-12,506
Closed -$411K – 2996
2021
Q3 		$411K Sell
12,506
-2,415
-16% -$94.1K ﹤0.01% 2546
2021
Q2 		$1.01M Buy
14,921
+8,045
+117% +$483K ﹤0.01% 2311
2021
Q1 		$388K Buy
6,876
+726
+12% +$51.1K ﹤0.01% 2620
2020
Q4 		$500K Sell
6,150
-2,049
-25% -$153K ﹤0.01% 2427
2020
Q3 		$583K Sell
8,199
-15,005
-65% -$1.17M ﹤0.01% 2321
2020
Q2 		$1.9M Buy
23,204
+21,415
+1,197% +$1.65M ﹤0.01% 1674
2020
Q1 		$105K Buy
+1,789
New +$146K ﹤0.01% 2718

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Russell Investments Group's AXSM Position: Q2 2026 in Review

Russell Investments Group increased its Axsome Therapeutics (AXSM) stake by 70% in Q2 2026, buying an estimated $5.39M and bringing the position to 60,592 shares worth $14.8M. The position accounts for 0.01% of the portfolio, ranked #864.

Russell Investments Group first reported a position in AXSM in Q1 2020 and has held it in 21 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Russell Investments Group held 60,592 shares of Axsome Therapeutics worth $14.8M as of Q2 2026.
  • Russell Investments Group bought 24,874 Axsome Therapeutics shares in Q2 2026, an estimated $5.39M.
  • Axsome Therapeutics made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #864 holding.
  • Russell Investments Group first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 21 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.